Fate Therapeutics Inc. buy BiotechBee
Start price
26.10.22
/
70%
€20.67
Target price
31.12.24
€35.00
Performance (%)
-41.33%
End price
21.12.22
€12.12
Summary
This prediction ended on 21.12.22 with a price of €12.12. The BUY prediction by BiotechBee for Fate Therapeutics Inc. performed very badly with a performance of -41.33%. BiotechBee has 70% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Fate Therapeutics Inc. | -0.173% | -0.173% | 62.050% |
iShares Core DAX® | 0.347% | 2.173% | 18.599% |
iShares Nasdaq 100 | 0.715% | 0.138% | 26.542% |
iShares Nikkei 225® | 1.522% | 2.003% | 13.220% |
iShares S&P 500 | 0.631% | 1.633% | 25.009% |
According to BiotechBee what are the pros and cons of Fate Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Fate Therapeutics Inc. diskutieren
Buy mit Kursziel 35,0
In the thread Trading Fate Therapeutics Inc.
Buy beendet